- Home
- PMF vs TKNO Comparison
PMF vs TKNO Comparison
Compare PMF & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMF
- TKNO
- Stock Information
- Founded
- PMF 2001
- TKNO 1996
- Country
- PMF United States
- TKNO United States
- Employees
- PMF N/A
- TKNO N/A
- Industry
- PMF Finance/Investors Services
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- PMF Finance
- TKNO Health Care
- Exchange
- PMF Nasdaq
- TKNO Nasdaq
- Market Cap
- PMF 249.4M
- TKNO 244.7M
- IPO Year
- PMF N/A
- TKNO 2021
- Fundamental
- Price
- PMF $10.09
- TKNO $5.02
- Analyst Decision
- PMF
- TKNO Buy
- Analyst Count
- PMF 0
- TKNO 2
- Target Price
- PMF N/A
- TKNO $5.00
- AVG Volume (30 Days)
- PMF 61.3K
- TKNO 125.7K
- Earning Date
- PMF 01-01-0001
- TKNO 11-07-2024
- Dividend Yield
- PMF 5.36%
- TKNO N/A
- EPS Growth
- PMF N/A
- TKNO N/A
- EPS
- PMF N/A
- TKNO N/A
- Revenue
- PMF N/A
- TKNO $34,940,000.00
- Revenue This Year
- PMF N/A
- TKNO $3.22
- Revenue Next Year
- PMF N/A
- TKNO $14.88
- P/E Ratio
- PMF N/A
- TKNO N/A
- Revenue Growth
- PMF N/A
- TKNO N/A
- 52 Week Low
- PMF $7.69
- TKNO $1.16
- 52 Week High
- PMF $10.56
- TKNO $5.46
- Technical
- Relative Strength Index (RSI)
- PMF 61.85
- TKNO 56.35
- Support Level
- PMF $10.03
- TKNO $4.68
- Resistance Level
- PMF $10.14
- TKNO $5.07
- Average True Range (ATR)
- PMF 0.13
- TKNO 0.36
- MACD
- PMF -0.01
- TKNO -0.00
- Stochastic Oscillator
- PMF 43.34
- TKNO 66.84
About PMF PIMCO Municipal Income Fund
PIMCO Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to seek to provide current income exempt from federal income tax. The fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal income tax.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.